This narrative state-of-the-art review paper describes the progress in the understanding and
treatment of Posttraumatic Stress Disorder (PTSD). Over the last four decades, the scientific …

Major depressive disorder (MDD) is a highly heterogeneous mental disorder, and its
complex etiology and unclear mechanism are great obstacles to the diagnosis and treatment …

Background: Growing numbers of people are using psychedelics for personal
psychotherapy outside clinical settings, but research on such use is scarce. Aims: This study …

Background: Posttraumatic stress disorder (PTSD) and depression are highly comorbid.
Psilocybin exerts substantial therapeutic effects on depression by promoting neuroplasticity …

The current standard of care in most uses of psychedelic medicines for the treatment of
psychiatric indications includes the provision of a supportive therapeutic context before …

In recent years, psychedelic-assisted psychotherapies have reentered the realm of rigorous
scientific inquiry, garnering much attention from both the psychiatric community and the …

Introduction Psilocybin-assisted therapy has shown significant promise in treating the cluster
of mood and anxiety symptoms that comprise post-traumatic stress disorder (PTSD) but has …

A sharp increase in the prevalence of neuropsychiatric disorders, including major
depression, anxiety, substance use disorders and posttraumatic stress disorder (PTSD) has …

Abstract With the Food and Drug Administration designation in 2017 of 3, 4-
methylenedioxymethamphetamine (MDMA) as a breakthrough therapy in post-traumatic …

Background: Expectancies, motives, and attitudes toward substances are cognitive factors
that partially account for substance use; however, existing measures tend to have …